GSK Egypt (BIOC): The Defensive Giant Under PressureGlaxoSmithKline S.A.E.EGX_DLY:BIOCmnmabroukw36ixGSK Egypt (BIOC): The Defensive Giant Under Pressure 💊📉 The Driver: Strong brand power in vaccines and specialty meds. It recently paid a 1.00 EGP dividend (Jan 2026), but high valuation is now the focus. 💰🧪 It is technically one of the most expensive stocks on the EGX relative to its earnings. ⚠️ Sharia Status: ✅ Compliant. A stable member of the EGX33 Shariah Index. ☪️📜 The Technical Trap: In a downtrend since the 81.50 EGP ATH (Sept 2025). It is currently hovering around 59.11 EGP, testing the Anchor VWAP of the last dip. 📉🪝 The Safety Floor: Below the VWAP, the 200-day MA at 57.50 EGP is the "last stand." A break here validates the "dark scenario" toward the 32.00 EGP 52-week low. 🛡️🥀 The Risks: Extremely expensive P/E (~51x) and thinning margins (2.6%) make it vulnerable to high interest rates. ⚠️🚩 Debt Coverage: Interest-bearing debt is not well-covered by its current operating cash flow.🚩 Verdict: A "Blue Chip" in a technical slump. No panic yet, but if 57.50 fails, the correction could turn into a deep dive. Watch the VWAP support closely! ⚖️🔥 If you like my posts, please follow and boost 🙌